메뉴 건너뛰기




Volumn 44, Issue 1, 2012, Pages 4-11

Pulmonary arterial hypertension: Advances in pathophysiology and management

Author keywords

Management; pathophysiology; pulmonary arterial hypertension

Indexed keywords

AMBRISENTAN; AMLODIPINE; ANTICOAGULANT AGENT; BERAPROST; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DIURETIC AGENT; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; PHOSPHODIESTERASE V INHIBITOR; POTASSIUM CHANNEL; PROSTACYCLIN; PROSTACYCLIN SYNTHASE; SEROTONIN; SEROTONIN TRANSPORTER; SILDENAFIL; SITAXSENTAN; TADALAFIL; UNIPROST; VARDENAFIL; VASODILATOR AGENT;

EID: 84856402597     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.91858     Document Type: Review
Times cited : (14)

References (68)
  • 1
    • 3142726157 scopus 로고    scopus 로고
    • Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines
    • Badesch DB, Abman SH, Ahearn GS, Barst RJ, Simonneau G, Vallerie V, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:35S-62.
    • (2004) Chest , vol.126
    • Badesch, D.B.1    Abman, S.H.2    Ahearn, G.S.3    Barst, R.J.4    Simonneau, G.5    Vallerie, V.6
  • 2
    • 34250870730 scopus 로고    scopus 로고
    • Medical therapy for pulmonary arterial hypertension: Updated ACCP evidence-based clinical practice guidelines
    • DOI 10.1378/chest.06-2674
    • Badesch DB, Abman SH, Simonneau G, Rubin LJ, Mclaughlin VV. Medical therapy for pulmonary arterial hypertension. Updated ACCP evidence-based clinical practice guidelines. Chest 2007;131:1917-28. (Pubitemid 46981654)
    • (2007) Chest , vol.131 , Issue.6 , pp. 1917-1928
    • Badesch, D.B.1    Abman, S.H.2    Simonneau, G.3    Rubin, L.J.4    McLaughlin, V.V.5
  • 3
    • 2942592213 scopus 로고    scopus 로고
    • Cardiovascular disease in non-western countries
    • DOI 10.1056/NEJMp048024
    • Reddy KS. Cardiovascular disease in non-western countries. N Engl J Med 2004;350:2438-40. (Pubitemid 38736540)
    • (2004) New England Journal of Medicine , vol.350 , Issue.24 , pp. 2438-2440
    • Reddy, K.S.1
  • 4
    • 47849100456 scopus 로고    scopus 로고
    • Pediatric heart care in india
    • Kumar RK, Shrivastava S. Pediatric heart care in India. Heart 2008;94:984-90.
    • (2008) Heart , vol.94 , pp. 984-990
    • Kumar, R.K.1    Shrivastava, S.2
  • 6
    • 0026831486 scopus 로고
    • Epidemiology of congenital and rheumatic heart disease in children
    • Gupta I, Gupta ML, Parihar A, Gupta CD. Epidemiology of congenital and rheumatic heart disease in children. J Indian Med Assoc 1992;90:57-9.
    • (1992) J Indian Med Assoc , vol.90 , pp. 57-59
    • Gupta, I.1    Gupta, M.L.2    Parihar, A.3    Gupta, C.D.4
  • 7
    • 0242294315 scopus 로고    scopus 로고
    • Epidemiology of streptococcal pharyngitis, rheumatic fever and rheumatic heart disease
    • Narula J, Virmani R, Reddy KS, Tandon R, editors Washington, DC; American Registry of Pathology;
    • Kumar RK, Rammohan R, Narula J, Kaplan EL. Epidemiology of streptococcal pharyngitis, rheumatic fever and rheumatic heart disease. In: Narula J, Virmani R, Reddy KS, Tandon R, editors. Rheumatic fever, Washington, DC; American Registry of Pathology; 1999. p. 41-78.
    • (1999) Rheumatic Fever , pp. 41-78
    • Kumar, R.K.1    Rammohan, R.2    Narula, J.3    Kaplan, E.L.4
  • 8
    • 3142692425 scopus 로고    scopus 로고
    • Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines
    • McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:14S-34.
    • (2004) Chest , vol.126
    • McGoon, M.1    Gutterman, D.2    Steen, V.3    Barst, R.4    McCrory, D.C.5    Fortin, T.A.6
  • 10
    • 0026628265 scopus 로고
    • An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension
    • Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992;327:70-5.
    • (1992) N Engl J Med , vol.327 , pp. 70-75
    • Christman, B.W.1    McPherson, C.D.2    Newman, J.H.3    King, G.A.4    Bernard, G.R.5    Groves, B.M.6
  • 12
    • 21744460365 scopus 로고    scopus 로고
    • Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells
    • DOI 10.1096/fj.04-3261fje
    • Sakao S, Taraseviciene-Stewart L, Lee JD, Wood K, Cool CD, Voelkel NF. Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. Faseb J 2005;19:1178-80. (Pubitemid 40946457)
    • (2005) FASEB Journal , vol.19 , Issue.9 , pp. 1178-1180
    • Sakao, S.1    Taraseviciene-Stewart, L.2    Lee, J.D.3    Wood, K.4    Cool, C.D.5    Voelkel, N.F.6
  • 13
    • 2342483718 scopus 로고    scopus 로고
    • Calcium and TRP channels in pulmonary vascular smooth muscle cell proliferation
    • Landsberg JW, Yuan JX. Calcium and TRP channels in pulmonary vascular smooth muscle cell proliferation. News Physiol Sci 2004;19:44-50.
    • (2004) News Physiol Sci , vol.19 , pp. 44-50
    • Landsberg, J.W.1    Yuan, J.X.2
  • 14
    • 0035859940 scopus 로고    scopus 로고
    • 1 and bone morphogenetic proteins
    • Morrell NW, Yang X, Upton PD, Jourdan KB, Morgan N, Sheares KK, et al. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Circulation 2001;104:790-5. (Pubitemid 32762677)
    • (2001) Circulation , vol.104 , Issue.7 , pp. 790-795
    • Morrell, N.W.1    Yang, X.2    Upton, P.D.3    Jourdan, K.B.4    Morgan, N.5    Sheares, K.K.6    Trembath, R.C.7
  • 17
    • 0036014810 scopus 로고    scopus 로고
    • Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?
    • DOI 10.1067/mlc.2002.122181
    • Eddahibi S, Raffestin B, Hamon M, Adnot S. Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension? J Lab Clin Med 2002;139:194-201. (Pubitemid 34557354)
    • (2002) Journal of Laboratory and Clinical Medicine , vol.139 , Issue.4 , pp. 194-201
    • Eddahibi, S.1    Raffestin, B.2    Hamon, M.3    Adnot, S.4
  • 18
    • 0037204990 scopus 로고    scopus 로고
    • Signal transduction by the tgf-beta superfamily
    • Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science 2002;296:1646-7.
    • (2002) Science , vol.296 , pp. 1646-1647
    • Attisano, L.1    Wrana, J.L.2
  • 21
    • 0033623296 scopus 로고    scopus 로고
    • Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding bmpr-ii, a receptor member of the tgf-beta family
    • Thomson JR, Machado RD, Pauciulo MW, Morgan NV, Humbert M, Elliott GC, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 2000;37:741-5.
    • (2000) J Med Genet , vol.37 , pp. 741-745
    • Thomson, J.R.1    MacHado, R.D.2    Pauciulo, M.W.3    Morgan, N.V.4    Humbert, M.5    Elliott, G.C.6
  • 22
    • 54049138069 scopus 로고    scopus 로고
    • Emerging concepts and translational priorities in pulmonary arterial hypertension
    • Michelakis ED, Wilkins MR, Rabinovitch M. Emerging concepts and translational priorities in pulmonary arterial hypertension. Circulation 2008;118:1486-95.
    • (2008) Circulation , vol.118 , pp. 1486-1495
    • Michelakis, E.D.1    Wilkins, M.R.2    Rabinovitch, M.3
  • 23
    • 0037623284 scopus 로고    scopus 로고
    • Primary pulmonary hypertension
    • DOI 10.1016/S0140-6736(03)13167-4
    • Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003;361:1533-44. (Pubitemid 36566349)
    • (2003) Lancet , vol.361 , Issue.9368 , pp. 1533-1544
    • Runo, J.R.1    Loyd, J.E.2
  • 24
    • 1642453778 scopus 로고    scopus 로고
    • Endothelial dysfunction in pulmonary hypertension
    • Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 2004;109:159-61.
    • (2004) Circulation , vol.109 , pp. 159-161
    • Budhiraja, R.1    Tuder, R.M.2    Hassoun, P.M.3
  • 29
    • 33749076068 scopus 로고    scopus 로고
    • Electrocardiography in the diagnosis of right ventricular hypertrophy in children
    • DOI 10.1542/peds.2005-2985
    • Puchalski MD, Lozier JS, Bradley DJ, Minich LL, Tani LY. Electrocardiography in the diagnosis of right ventricular hypertrophy in children. Pediatrics 2006;118:1052-5. (Pubitemid 46090045)
    • (2006) Pediatrics , vol.118 , Issue.3 , pp. 1052-1055
    • Puchalski, M.D.1    Lozier, J.S.2    Bradley, D.J.3    Minich, L.L.4    Tani, L.Y.5
  • 31
    • 33646476400 scopus 로고    scopus 로고
    • Serum n-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension
    • Fijalkowska A, Kurzyna M, Torbicki A, Szewczysk G, Florczyk M, Pruszczyk P, et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006;129:1313-21.
    • (2006) Chest , vol.129 , pp. 1313-1321
    • Fijalkowska, A.1    Kurzyna, M.2    Torbicki, A.3    Szewczysk, G.4    Florczyk, M.5    Pruszczyk, P.6
  • 33
    • 0042433550 scopus 로고    scopus 로고
    • Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension
    • DOI 10.1161/01.CIR.0000084544.54513.E2
    • Torbicki A, Kurzyna M, Kuca P, Fijalkowska A, Sikora J, Florczyk M, et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003;108:844-8. (Pubitemid 37022127)
    • (2003) Circulation , vol.108 , Issue.7 , pp. 844-848
    • Torbicki, A.1    Kurzyna, M.2    Kuca, P.3    Fijalkowska, A.4    Sikora, J.5    Florczyk, M.6    Pruszczyk, P.7    Burakowski, J.8    Wawrzynska, L.9
  • 37
    • 0026632785 scopus 로고
    • The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
    • Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327:76-81.
    • (1992) N Engl J Med , vol.327 , pp. 76-81
    • Rich, S.1    Kaufmann, E.2    Levy, P.S.3
  • 38
    • 0026628265 scopus 로고
    • An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension
    • Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992;327:70-5.
    • (1992) N Engl J Med , vol.327 , pp. 70-75
    • Christman, B.W.1    McPherson, C.D.2    Newman, J.H.3    King, G.A.4    Bernard, G.R.5    Groves, B.M.6
  • 41
    • 0030031888 scopus 로고    scopus 로고
    • A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
    • Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996;334:296-302.
    • (1996) N Engl J Med , vol.334 , pp. 296-302
    • Barst, R.J.1    Rubin, L.J.2    Long, W.A.3    McGoon, M.D.4    Rich, S.5    Badesch, D.B.6
  • 43
    • 33645119109 scopus 로고    scopus 로고
    • Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: A prospective, multicentre, open label, 12-week trial
    • Tapson VF, Gomberg-Maitland M, McLaughlin VV, Benza RL, Widlitz AC, Krichman A, et al. Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: A prospective, multicentre, open label, 12-week trial. Chest 2006;129:683-8.
    • (2006) Chest , vol.129 , pp. 683-688
    • Tapson, V.F.1    Gomberg-Maitland, M.2    McLaughlin, V.V.3    Benza, R.L.4    Widlitz, A.C.5    Krichman, A.6
  • 48
    • 27744444638 scopus 로고    scopus 로고
    • Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
    • DOI 10.1136/thx.2005.040618
    • Sitbon O, McLaughlin VV, Badesch DB, Barst RJ, Black C, Galiè N, et al. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. Thorax 2005;60:1025-30. (Pubitemid 41705471)
    • (2005) Thorax , vol.60 , Issue.12 , pp. 1025-1030
    • Sitbon, O.1    McLaughlin, V.V.2    Badesch, D.B.3    Barst, R.J.4    Black, C.5    Galie, N.6    Humbert, M.7    Rainisio, M.8    Rubin, L.J.9    Simonneau, G.10
  • 50
    • 44949256178 scopus 로고    scopus 로고
    • Endothelin receptor antagonists for pulmonary arterial hypertension: Rationale and place in therapy
    • DOI 10.2165/00129784-200808030-00004
    • Price LC, Howard LS. Endothelin receptor antagonists for pulmonary arterial hypertension. Rationale and place in therapy. Am J Cardiovasc Drugs 2008;8:171-85. (Pubitemid 351812270)
    • (2008) American Journal of Cardiovascular Drugs , vol.8 , Issue.3 , pp. 171-185
    • Price, L.C.1    Howard, L.S.G.E.2
  • 51
    • 79960992464 scopus 로고    scopus 로고
    • Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension
    • Safdar Z. Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension. Vasc Health Risk Manag 2011;7:119-24.
    • (2011) Vasc Health Risk Manag , vol.7 , pp. 119-124
    • Safdar, Z.1
  • 54
    • 47549106387 scopus 로고    scopus 로고
    • Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension
    • DOI 10.1378/chest.07-2111
    • Benza RI, Rayburn BK, Tallaj JA, Pamboukian SV, Bourge RC. Treprostinil based therapy in the treatment of moderate to severe pulmonary arterial hypertension. Chest 2008;134:139-45. (Pubitemid 352008775)
    • (2008) Chest , vol.134 , Issue.1 , pp. 139-145
    • Benza, R.L.1    Rayburn, B.K.2    Tallaj, J.A.3    Pamboukian, S.V.4    Bourge, R.C.5
  • 55
    • 0036490437 scopus 로고    scopus 로고
    • Graded balloon atrial septostomy in sever pulmonary hypertension
    • Kothari SS, Yusuf A, Juneja R, Yadav R, Naik N. Graded balloon atrial septostomy in sever pulmonary hypertension. Indian Heart J 2002;54:164-9.
    • (2002) Indian Heart J , vol.54 , pp. 164-169
    • Kothari, S.S.1    Yusuf, A.2    Juneja, R.3    Yadav, R.4    Naik, N.5
  • 56
  • 62
    • 0034702908 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension
    • Nagaya N, Nishikimi T, Uematsu M, Satoh T, Kyotani S, Sakamaki F, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000;102:865-70.
    • (2000) Circulation , vol.102 , pp. 865-870
    • Nagaya, N.1    Nishikimi, T.2    Uematsu, M.3    Satoh, T.4    Kyotani, S.5    Sakamaki, F.6
  • 65
    • 78651369037 scopus 로고    scopus 로고
    • Gene therapy for pulmonary hypertension: Prospects and challenges
    • Reynolds PN. Gene therapy for pulmonary hypertension: prospects and challenges. Expert Opin. Biol Ther 2011;11:133-43.
    • (2011) Expert Opin. Biol Ther , vol.11 , pp. 133-143
    • Reynolds, P.N.1
  • 66
    • 25444484658 scopus 로고    scopus 로고
    • Imatinib for the treatment of pulmonary arterial hypertension [1]
    • DOI 10.1056/NEJMc051946
    • Ghofrani HA, Seeger W, Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 2005;353:1412-3. (Pubitemid 41362714)
    • (2005) New England Journal of Medicine , vol.353 , Issue.13 , pp. 1412-1413
    • Ghofrani, H.A.1    Seeger, W.2    Grimminger, F.3
  • 67
    • 33746745449 scopus 로고    scopus 로고
    • Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension [3]
    • Patterson KC, Weissmann A, Ahmadi T, Farber HW. Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension. Ann Intern Med 2006;145:152-3. (Pubitemid 46780594)
    • (2006) Annals of Internal Medicine , vol.145 , Issue.2 , pp. 152-153
    • Patterson, K.C.1    Weissmann, A.2    Ahmadi, T.3    Farber, H.W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.